Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitafol-OB + DHA is a prescription-grade prenatal multivitamin and mineral supplement combined with docosahexaenoic acid (DHA). Distributed by Exeltis USA, it is specifically formulated to provide essential nutritional support prior to conception, throughout pregnancy, and during the postnatal period for both lactating and non-lactating mothers. The product is available as a kit containing a light blue caplet with essential vitamins (including folic acid, vitamin D3, and B-complex) and minerals (including iron as ferrous fumarate, calcium, and zinc), alongside an amber-colored softgel capsule containing 250 mg of DHA derived from natural algal oil. This combination is designed to support fetal brain and eye development through DHA and prevent neural tube defects through folic acid supplementation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vitafol-OB + docosahexaenoic acid.